194 related articles for article (PubMed ID: 37342413)
1. Site and Mechanism of ML252 Inhibition of Kv7 Voltage-Gated Potassium Channels.
Kanyo R; Lamothe SM; Urrutia A; Goodchild SJ; Allison WT; Dean R; Kurata HT
Function (Oxf); 2023; 4(4):zqad021. PubMed ID: 37342413
[TBL] [Abstract][Full Text] [Related]
2. Functional and behavioral signatures of Kv7 activator drug subtypes.
Kanyo R; Wang CK; Locskai LF; Li J; Allison WT; Kurata HT
Epilepsia; 2020 Aug; 61(8):1678-1690. PubMed ID: 32652600
[TBL] [Abstract][Full Text] [Related]
3. Molecular expression and functional features of Kv7 channels in human prostate smooth muscle.
Choi J; Han DH; Chae MR; Sung HH; Kang SJ; Shin J; Lee SW
Andrology; 2021 May; 9(3):933-943. PubMed ID: 33420748
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673.
Brueggemann LI; Haick JM; Cribbs LL; Byron KL
Mol Pharmacol; 2014 Sep; 86(3):330-41. PubMed ID: 24944189
[TBL] [Abstract][Full Text] [Related]
5. K
Provence A; Angoli D; Petkov GV
J Pharmacol Exp Ther; 2018 Jan; 364(1):131-144. PubMed ID: 29084816
[TBL] [Abstract][Full Text] [Related]
6. Characterization and functional roles of KCNQ-encoded voltage-gated potassium (Kv7) channels in human corpus cavernosum smooth muscle.
Lee JH; Chae MR; Kang SJ; Sung HH; Han DH; So I; Park JK; Lee SW
Pflugers Arch; 2020 Jan; 472(1):89-102. PubMed ID: 31919767
[TBL] [Abstract][Full Text] [Related]
7. Sequence determinants of subtype-specific actions of KCNQ channel openers.
Wang AW; Yang R; Kurata HT
J Physiol; 2017 Feb; 595(3):663-676. PubMed ID: 27506413
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.
Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K
FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701
[TBL] [Abstract][Full Text] [Related]
9. Four drug-sensitive subunits are required for maximal effect of a voltage sensor-targeted KCNQ opener.
Wang AW; Yau MC; Wang CK; Sharmin N; Yang RY; Pless SA; Kurata HT
J Gen Physiol; 2018 Oct; 150(10):1432-1443. PubMed ID: 30166313
[TBL] [Abstract][Full Text] [Related]
10. Effects of novel subtype selective M-current activators on spinal reflexes in vitro: Comparison with retigabine.
Vicente-Baz J; Lopez-Garcia JA; Rivera-Arconada I
Neuropharmacology; 2016 Oct; 109():131-138. PubMed ID: 27263036
[TBL] [Abstract][Full Text] [Related]
11. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
Padilla K; Wickenden AD; Gerlach AC; McCormack K
Neurosci Lett; 2009 Nov; 465(2):138-42. PubMed ID: 19733209
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
[TBL] [Abstract][Full Text] [Related]
13. Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy.
Li J; Maghera J; Lamothe SM; Marco EJ; Kurata HT
Mol Pharmacol; 2020 Sep; 98(3):192-202. PubMed ID: 32580997
[TBL] [Abstract][Full Text] [Related]
14. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
Bentzen BH; Schmitt N; Calloe K; Dalby Brown W; Grunnet M; Olesen SP
Neuropharmacology; 2006 Nov; 51(6):1068-77. PubMed ID: 16904708
[TBL] [Abstract][Full Text] [Related]
15. Competition of calcified calmodulin N lobe and PIP2 to an LQT mutation site in Kv7.1 channel.
Tobelaim WS; Dvir M; Lebel G; Cui M; Buki T; Peretz A; Marom M; Haitin Y; Logothetis DE; Hirsch JA; Attali B
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E869-E878. PubMed ID: 28096388
[TBL] [Abstract][Full Text] [Related]
16. The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility.
Provence A; Malysz J; Petkov GV
J Pharmacol Exp Ther; 2015 Sep; 354(3):290-301. PubMed ID: 26087697
[TBL] [Abstract][Full Text] [Related]
17. PIP
Pant S; Zhang J; Kim EC; Lam K; Chung HJ; Tajkhorshid E
Commun Biol; 2021 Oct; 4(1):1189. PubMed ID: 34650221
[TBL] [Abstract][Full Text] [Related]
18. The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine.
Syeda R; Santos JS; Montal M
J Biol Chem; 2016 Feb; 291(6):2931-7. PubMed ID: 26627826
[TBL] [Abstract][Full Text] [Related]
19. Pore- and voltage sensor-targeted KCNQ openers have distinct state-dependent actions.
Wang CK; Lamothe SM; Wang AW; Yang RY; Kurata HT
J Gen Physiol; 2018 Dec; 150(12):1722-1734. PubMed ID: 30373787
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of potassium channels in Kv7.2 G271V mutant causing early onset familial epilepsy.
Wang J; Li Y; Hui Z; Cao M; Shi R; Zhang W; Geng L; Zhou X
Brain Res; 2015 Aug; 1616():112-22. PubMed ID: 25960349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
